Pacira | PCRX - Ordinary Share Capital


Pacira reported $39.82M in Ordinary Share Capital for its fiscal quarter ending in June of 2026.





Ordinary Share Capital Change Date
Astellas Pharma JPY 1.79B 1.52M Jun/2026
Bristol-Myers Squibb USD 2.04B 1.74B Sep/2025
Cara Therapeutics USD 9.38M 2.01K Mar/2026
Coherus Biosciences USD 121.16M 4.92M Dec/2025
Heron Therapeutics USD 188.31M 4.99M Dec/2025
Ironwood Pharmaceuticals USD 160K 0 Dec/2024
J&J USD 2.41B 1.35M Mar/2026
Ligand Pharmaceuticals USD 19.66M 19.64M Sep/2025
Nektar Therapeutics USD 29.47M 9.09M Mar/2026
Novo Nordisk DKK 4.43B 13.25M Jun/2026
Omeros USD 611K 17K Dec/2023
Pacira USD 39.82M 512K Jun/2026
Perrigo USD 138.1M 500K Mar/2026
Pfizer USD 5.7B 0 Jun/2026
Supernus Pharmaceuticals USD 58.16M 124K Jun/2026
Teva Pharmaceutical Industries USD 1.16B 1000K Jun/2026
Xeris Pharmaceuticals USD 172.56M 6.34M Mar/2026
Zoetis USD 420.35M 4.58M Mar/2026